Evidence map›Paper›PMID 36254270›Full record

ArticleHealth and technology2022

A New method for promote the performance of deep learning paradigm in diagnosing breast cancer: improving role of fusing multiple views of thermography images.

Mahsa Ensafi, Mohammad Reza Keyvanpour, Seyed Vahab Shojaedini

Abstract read
In one paragraph

Article in Health and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mahsa EnsafiFaculty of Engineering and Technology, Alzahra University, Tehran, Iran.
Mohammad Reza KeyvanpourFaculty of Engineering and Technology, Alzahra University, Tehran, Iran.
Seyed Vahab ShojaediniDepartment of Biomedical Engineering, Iranian Research Organization for Science and Technology, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Breast cancer is one of the deadliest cancers among women worldwide which its early detection may significantly reduce its mortality rate. Thermgraphy is a new, non-invasive, non-painful, and low-cost modality that detects abnormalities by detecting heat from the breast surface. Method: Recent research has applied deep learning to early breast cancer diagnosis via thermography, using only the frontal view of thermograms. We combine several views of thermal images to improve the performance of pre-trained deep learning architectures in this article. This goal is achieved by combining frontal-45 data with lateral-45 and lateral45 thermograms to construct a detection model that utilizes transfer learning. Result: Research in this area uses the Database for Mastology Research (DMR) with infrared images. In this study, transfer based deep learning methods are demonstrated to be effective in fusing several views of thermograms to diagnose breast cancer in a manner that can result in a sensitivity increase of 2-15 percent and a specificity increase of 2-30 percent compared to other deep learning-based or handcrafted schemes. Conclusion: Using multiple views of thermograms and transfer learning, this paper proposes a method for improving breast cancer diagnosis. Using methods based on deep learning and methods based on hand-crafted features, we evaluated the performance of the proposed model. Using the obtained results as a basis for future research, the proposed design can be improved and developed as a valid approach in interpreting breast thermography images.

Indexed as

Breast cancerDeep learningThermographyTransfer learning

Identifiers

PMID36254270
PMCPMC9556139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.